Your session is about to expire
← Back to Search
Treatment Arm for Oropharyngeal Cancer (ARTHOUSE Trial)
ARTHOUSE Trial Summary
This trial wants to understand more about patients with a type of throat cancer caused by the HPV virus. They want to identify the patients who are at the highest risk of the cancer coming back after treatment.
ARTHOUSE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowARTHOUSE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ARTHOUSE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the enrollment for this medical study currently accepting new participants?
"Indeed, the information provided on clinicaltrials.gov indicates that this trial is actively seeking eligible candidates. It was initially posted on December 20th, 2023 and recently updated on January 22nd, 2024. The study aims to recruit a total of 20 participants from one designated location."
What is the level of risk associated with the Treatment Arm for patients?
"Based on our evaluation at Power, the safety level of the Treatment Arm is rated as 2. This assessment aligns with it being a Phase 2 trial where there is limited data supporting its safety but no evidence yet regarding efficacy."
What is the current number of participants being recruited for this research study?
"Indeed, the information available on clinicaltrials.gov indicates that this study is currently in the process of recruiting eligible participants. The trial was initially posted on December 20th, 2023 and received its most recent update on January 22nd, 2024. To complete the study successfully, researchers aim to enroll a total of 20 individuals from one designated location."
Share this study with friends
Copy Link
Messenger